Efforts to fight HIV/AIDS, NTDs should be integrated

NewsGuard 100/100 Score

"The neglected tropical diseases (NTDs) produce a devastating level of chronic disability in sub-Saharan Africa, with some estimates suggesting that the NTD disease burden exceeds tuberculosis and is one-half that of malaria," Julie Noblick and Richard Skolnick of George Washington University and Peter Hotez of the Sabin Vaccine Institute write in a PLoS Neglected Tropical Diseases editorial. With noted relationships between the prevalence of NTDs and HIV, the diseases "demand a public health response from the established global HIV/AIDS community, in parallel with efforts to scale up NTD control," they argue.

"We support the U.S. President's call for integration and would favor strategic planning to examine how the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) … could advance efforts to coordinate and link the HIV/AIDS programs they support with NTD control and elimination programs," they write, before discussing what such integration might require (7/26).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New report on HIV drug resistance: Challenges and recommendations